Why HROW? Harrow, Inc. Analysis, Price & AI Insights | Whystock
HROW
$40.90+0.37 (+0.91%)
Market ClosedLast close May 1
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States.